Structure-based Drug Design on MolGenBench Proteins in CrossDock
37.52Pass RateEvoEGF-Mol
Evaluation Results
| Method | Links | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| EvoEGF-Mol2026.01 | 37.52 | 7 | 0.03 | 0.01 | 78 | 1 | 4 | 2 | |
| EvoEGF-Mol2026.01 | 31.79 | 72 | 3.88 | 108 | 52 | 30 | 3 | 0 | |
| MolCRAFT2026.01 | 25.93 | 3 | 0.01 | 0 | 82 | 0 | 1 | 2 | |
| MolCRAFT2026.01 | 23.07 | 66 | 3.5 | 70 | 52 | 33 | 0 | 0 | |
| DecompDiff2026.01 | 22.9 | 2 | 0 | 0 | 80 | 0 | 2 | 0 | |
| Pocket2Mol2026.01 | 20.09 | 0 | 0 | 0 | 85 | 0 | 0 | 0 | |
| DecompDiff2026.01 | 16.11 | 65 | 4.99 | 81 | 46 | 35 | 1 | 0 | |
| Pocket2Mol2026.01 | 11.58 | 57 | 1.75 | 61 | 54 | 31 | 0 | 0 | |
| TargetDiff2026.01 | 5.99 | 0 | 0 | 0 | 85 | 0 | 0 | 0 | |
| TargetDiff2026.01 | 5.82 | 62 | 1.73 | 45 | 38 | 45 | 2 | 0 |